TerminatedNCT03643159
Official study titleA Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
This study ended early.
Multiple locations, including Santa RosaDepression, Bipolarity, ...Medication studyAges 18–63
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01670019
Official study titleA Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
This study has finished and is no longer accepting participants.
Multiple locations, including AugustaDepression, SchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Duke University
CompletedNCT04285515
What is this study about?Researchers compared Lumateperone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveDepression, BipolarityMedication studyAges 18–75
- Countries
- United States, Bulgaria, Russia, + 2 others
- Sponsor
- Intra-Cellular Therapies, Inc.
UnknownNCT06391723
Official study titleClinical, Cognitive and Neural Effect of Potentiation of Electroconvulsive Therapy (ECT) by Repetitive Transcranial Magnetic Stimulation (rTMS) at 10 ECT in Patients With Characterized Pharmacoresistant Depressive Episode
Current recruitment status is unconfirmed.
Location not clearly listedDepressionDevice studyAges 18–70
- Countries
- Sponsor
- Centre Hospitalier du Rouvray
CompletedNCT02977299
Official study titleAugmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With Treatment Resistant Depression (ASCERTAIN-TRD)
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–80
- Countries
- United States, Canada
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01898429
Official study titleDeep Brain Stimulation for Treatment-Resistant Depression
This study has finished and is no longer accepting participants.
In LebanonDepression, BipolarityDevice studyAges 22–70
- Countries
- United States
- Sponsor
- Paul Holtzheimer
Active Not RecruitingNCT05434156
Official study titleA Phase I, Randomised, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Intravenous Doses of ELE-101 in Healthy Adult Participants (Part 1) and Part 2, Open-Label Study to Evaluate a Range of Pharmacodynamic Effects of a Single Intravenous Dose of ELE-101 in Patients With Major Depressive Disorder.
This study is no longer accepting new participants.
Multiple locations, including LiverpoolDepressionMedication studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- Eleusis Therapeutics
CompletedNCT02722967
Official study titleA Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
This study has finished and is no longer accepting participants.
Multiple locations, including Granada HillsDepression, Schizophrenia, ...Medication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT04448327
Official study titleSex-Dependent Impact of Transcutaneous Vagal Nerve Stimulation on the Stress Response Circuitry and Autonomic Dysregulation in Major Depression
This study has finished and is no longer accepting participants.
In CharlestownDepressionDevice studyAges 50–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT03142919
Official study titleResponse to Inflammatory Challenge in Major Depressive Disorder
This study has finished and is no longer accepting participants.
In TulsaDepressionPlacebo comparisonAges 18–55
- Countries
- United States
- Sponsor
- Laureate Institute for Brain Research, Inc.
Active Not RecruitingNCT05910957
Official study titleMulti-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics: the MACADAMIA Pilot Study
This study is no longer accepting new participants.
In JacksonvilleDepression, SchizophreniaObservational studyAges 20–62
- Countries
- United States
- Sponsor
- Mayo Clinic
WithdrawnNCT04159012
Official study titleNESBID: Neuro-Stimulation of the Brain in Depression. A Randomized, Controlled Clinical Trial of Transcranial Direct Current Stimulation Augmentation, as Compared to Sham Therapy, in the Treatment of Ultra-resistant Major Depressive Disorder
This study was withdrawn before enrollment.
In EdmontonDepressionDevice studyAges 18+
- Countries
- Canada
- Sponsor
- University of Alberta
